ZNF33A Activators
ZNF33A, a member of the Krüppel C2H2-type zinc-finger protein family, plays a crucial role in the regulation of gene expression. Zinc-finger proteins are known for their binding to DNA and influencing the transcription of genes, making them integral components in developmental processes, differentiation, and cellular proliferation. ZNF33A, through its zinc-finger domains, specifically binds to DNA sequences, acting as a transcription factor that either activates or represses the expression of target genes. The ability of ZNF33A to interact with DNA and modulate gene expression underscores its importance in the intricate network of cellular regulation, where it may influence a wide array of biological processes, including growth regulation, apoptosis, and response to environmental stimuli. The precise mechanisms by which ZNF33A controls gene expression and the specific genes it targets are critical areas of research that could provide insights into its role in cellular physiology and pathology.
The activation of ZNF33A as a transcription factor likely involves several layers of regulation, including post-translational modifications, interactions with co-factors, and the availability of binding sites within the genome. Post-translational modifications, such as phosphorylation or sumoylation, can alter the conformation of ZNF33A, affecting its ability to bind DNA or interact with other proteins within the transcriptional machinery. Additionally, the interaction of ZNF33A with co-regulatory proteins can modulate its activity, enhancing or inhibiting its capacity to influence gene expression. The accessibility of ZNF33A to its DNA binding sites is another critical factor, which can be influenced by chromatin structure and the presence of epigenetic marks that either promote or inhibit transcription factor binding. Understanding the mechanisms that activate ZNF33A and how it is integrated into the broader regulatory networks within the cell is essential for elucidating its function in health and disease.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine, a DNA methyltransferase inhibitor, may indirectly affect ZNF33A by altering gene expression and epigenetic regulation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, a histone deacetylase inhibitor, could indirectly impact ZNF33A function by modifying chromatin structure and gene regulation. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
SAHA, another histone deacetylase inhibitor, may influence ZNF33A activity indirectly through its effects on chromatin remodeling and gene expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Decitabine, a DNA methyltransferase inhibitor, could affect ZNF33A function indirectly by modulating epigenetic landscapes. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic Acid, a histone deacetylase inhibitor, might indirectly impact ZNF33A by influencing gene expression and chromatin dynamics. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
Panobinostat, a broad-spectrum histone deacetylase inhibitor, may have an indirect effect on ZNF33A through its role in gene regulation. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
Romidepsin, a selective histone deacetylase inhibitor, could indirectly influence ZNF33A activity by modulating gene expression patterns. | ||||||
SGI-1027 | 1020149-73-8 | sc-473875 | 10 mg | $213.00 | ||
SGI-1027, a DNA methyltransferase inhibitor, might affect ZNF33A function indirectly by altering epigenetic regulation. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1, a BET bromodomain inhibitor, may influence ZNF33A activity indirectly by impacting transcription regulation. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
Mocetinostat, a histone deacetylase inhibitor, could have an indirect impact on ZNF33A through its effects on gene expression and chromatin structure. | ||||||